SCHEMBL320044

SCHEMBL320044

CC(O)C(=O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.57
ALDH1A1 P00352 7/20 0.52
HPGD P15428 2/20 0.52
CYP19A1 P11511 2/20 0.51
MAPT P10636 3/20 0.47
TSHR P16473 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TRPA1 O75762 2/20 0.46
TRPM8 Q7Z2W7 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
MAPK1 P28482 1/20 0.46
LMNA P02545 2/20 0.44
USP2 O75604 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL81703 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL12449339 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL13430521 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL7636456 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL12449351 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL471089 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL23196361 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL12522387 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL15291348 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL15697973 1.00 EPHX1 (0.57) EPHX1ALDH1A1HPGDCYP19A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122032439-A Preparation method of multi-stimulus response type multi-chamber microcapsule 北京工商大学 2026-05-15 CN claimed
EP-4734958-A1 TOPICAL COMPOSITION FOR PAIN RELIEF Kenvue Brands LLC (US) 2026-05-06 EP claimed
US-12601929-B2 Contact lens COOPERVISION INTERNATIONAL LIMITED (GB) 2026-04-14 US claimed
US-20250332126-A1 TOPICAL COMPOSITION FOR PAIN RELIEF JOHNSON & JOHNSON CONSUMER INC (US) 2025-10-30 US claimed
EP-4577188-A1 TOPICAL COMPOSITION FOR PAIN RELIEF Kenvue Brands LLC (US) 2025-07-02 EP claimed
US-20250170085-A1 TOPICAL FORMULATION TO DECREASE SKIN INFLAMMATION OR REDNESS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2025-05-29 US claimed
CN-119970593-A Sun-screening composition, application thereof and skin care product 东烽化学(杭州)有限公司广州分公司 2025-05-13 CN claimed
CN-119970600-A Antioxidant and ultraviolet-proof nursing composition and preparation method thereof 厦门稀土材料研究所 2025-05-13 CN claimed
CN-119768152-A Topical composition for pain relief 科赴品牌有限责任公司 2025-04-04 CN claimed
CN-119745767-A Dark circle-fading composition containing camellia chrysantha extract, and preparation method and application thereof 诺德溯源(广州)生物科技有限公司 2025-04-04 CN claimed
CN-108261357-A A kind of novel face cleaning beans and preparation method thereof 广州芬臣生物科技有限公司 2018-07-10 CN claimed
CN-105395378-B A kind of sheet microcapsules containing refrigerant formula 重庆小丸科贸有限公司 2018-07-10 CN claimed
EP-3342418-A1 ACNE REMOVING SKIN CARE PRODUCT AND PREPARATION METHOD THEREOF Infinitus (China) Company Ltd. (CN) 2018-07-04 EP claimed
US-20170354834-A1 ACNE REMOVING SKIN CARE PRODUCT AND PREPARATION METHOD THEREOF INFINITUS (CHINA) COMPANY LTD. (CN) 2017-12-14 US claimed
WO-2017136515-A1 CHEMICALS AND METHODS TO PREVENT AND TREAT TGF-BETA MEDIATED ACTIVATION OF FIBROBLASTS TO REDUCE AND TREAT CANCER AND FIBROSIS CARDELLI JAMES ALLEN (US) 2017-08-10 WO claimed
CN-105456066-A Novel face-cleansing composition and preparation method of finished product of face-cleansing composition PENG ZAIHUI 2016-04-06 CN claimed
CN-1300095-C Coolant solutions and compositions comprising the sameitle GIVAUDAN SA (CH) 2007-02-14 CN claimed
US-7078050-B2 White cream bacteriostats, fungicide as vehicle for drug; receptivity FUSCO NORMAJEAN 2006-07-18 US claimed
CN-1692096-A Coolant solutions and compositions containing same GIVAUDAN SA (CH) 2005-11-02 CN claimed
US-20050053595-A1 Composition for topical treatment FUSCO NORMAJEAN (US) 2005-03-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12601929-B2 Contact lens TRPM8, TRPM7, TRPM5 EPHX1 3263/4885ALDH1A1 4075/4885HPGD 1367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.